Volume reduction versus radiation dose for tumors in previously untreated lymphoma patients who received iodine-131 tositumomab therapy. Conjugate views compared with a hybrid method.

@article{Koral2002VolumeRV,
  title={Volume reduction versus radiation dose for tumors in previously untreated lymphoma patients who received iodine-131 tositumomab therapy. Conjugate views compared with a hybrid method.},
  author={Kenneth F. Koral and Isaac R. Francis and Stewart Kroll and Kenneth R. Zasadny and Mark S. Kaminski and Richard L. Wahl},
  journal={Cancer},
  year={2002},
  volume={94 4 Suppl},
  pages={
          1258-63
        }
}
BACKGROUND A Phase II study of previously untreated patients with malignant low grade follicular lymphoma given a combination of unlabeled tositumomab and tositumomab labeled with iodine-131 has recently been completed. The responses of these patients have been characterized, and for some of them tumor dosimetry during therapy has been estimated not only by pretherapy tracer conjugate views but also by a hybrid method. METHODS Available patients were studied if they had had a pelvic or… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 13 CITATIONS

Formation of Sulfonamide Bonds Through Reaction of Dyes with Serum Proteins

VIEW 8 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy

  • European Journal of Nuclear Medicine and Molecular Imaging
  • 2014
VIEW 1 EXCERPT
CITES METHODS

90Y Bremsstrahlung imaging for absorbed-dose assessment in high-dose radioimmunotherapy.

  • Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • 2010
VIEW 1 EXCERPT
CITES BACKGROUND

Dosimetry of internal emitters.

  • Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • 2005
VIEW 2 EXCERPTS
CITES METHODS & BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 10 REFERENCES

Initial results for Hybrid SPECT--conjugate-view tumor dosimetry in 131I-anti-B1 antibody therapy of previously untreated patients with lymphoma.

  • Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • 2000
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Tumor response predictors in radioimmunotherapy of previously untreated non-Hodgkin’s lymphoma: (NHL) with iodine-131 tositumomab

KR Zasadny, SG Rommelfanger, +3 authors R Stagg
  • J Nucl Med
  • 2000
VIEW 1 EXCERPT

Iodine - 131 – anti B 1 antibody for previously untreated follicular lymphoma ( FL ) : clinical and molecular remissions [ Abstract 6 ] . American Society of Clinical Oncology Annual Meeting

MS Kaminski, T Gribbin, J Estes, CW Ross, D Regan
  • Proc Am Soc Clin Oncol
  • 1998

Iodine-131 anti-B1 antibody for B-cell lymphoma: an update on the Michigan Phase I experience.

  • Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • 1998
VIEW 1 EXCERPT

Iodine-131–anti B1 antibody for previously untreated follicular lymphoma (FL): clinical and molecular remissions [Abstract 6

MS Kaminski, T Gribbin, +3 authors K Zasadny
  • American Society of Clinical Oncology Annual Meeting. Proc Am Soc Clin Oncol 1998;17:2a
  • 1998
VIEW 1 EXCERPT

Iodine - 131 anti - B 1 antibody for B - cell lymphoma : single center experience with iodine - 131 tositumomab ra - dioimmunotherapy for previously untreated follicular lymphoma

RL Wahl, KR Zasadny, +3 authors DD Regan
  • J Nucl Med